News and Announcements
Leaf Resouces (ASX: LER) Hosting Investor Events in Sydney, Brisbane, Perth & Melbourne
- Published July 07, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Leaf Resources Invites you to attend Investor Presentation for 2017. Leaf Resources is hosting shareholder presentations to give investors a unique opportunity to meet and network with our World Class Partner Claeris and to hear about the Company’s progress in Malaysia.
KEY TAKEAWAYS:
- This is a free event for Shareholders, Sophisticated and Accredited Investors, Stockbrokers and Fund Managers.
- Malaysia provides a unique combination of all the attributes necessary to be a successful location for a ‘platform’ Glycell facility.
- These attributes include abundant biomass resources, Malaysia’s advantageous location within the ASEAN region, and the active commitment of both the Federal and State Governments.
• Malaysia has a forward thinking economic development biotechnology philosophy supported at the highest government levels, that is focused on the bio-economy.
Meet with Managing Director of Leaf Resources, Ken Richards and Managing Partner of Claeris, Chuck Davis. Chuck is responsible for strategic planning, corporate development, and capital formation. Mr Davis brings more that 30 years of experience in corporate finance and strategic advisory roles with First Boston, Merril Lynch, UBS, Regency Energy Partners and Atmos Energy.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
